跳至主要内容
临床试验/EUCTR2013-004505-14-NO
EUCTR2013-004505-14-NO进行中(未招募)1 期

Antibiotic treatment in patients with chronic low back pain and Modic Changes: a double-blind randomized placebo-controlled trial

Oslo University Hospital HF, Ullevål Hospital, FORMI-Formidlingsenheten for muskel- og skjelettlidelser0 个研究点目标入组 280 人开始时间: 2016年8月31日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
280

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion criteria will be as follows:
  • Age between 18 and 65 years
  • LBP of > 6 months duration in the area from L1 to L5 with a Numerical Rating Scale (NRS) score of ? 5 (mean of three NRS scales; current LBP, the worst LBP within the last 2 weeks, and usual/mean LBP within the last 2 weeks).
  • MRI-confirmed disc herniation within the preceding 2 years or degenerated disc (Pfirrmann grade ? 348) at level L3/L4, L4/L5 or L5/S1.
  • MC type I or type II adjacent to a previously herniated disc or adjacent to a degenerated disc (Pfirrmann grade ? 348), based on T1- and T2 weighted MRI.
  • Both conservative and surgically treated patients will be included.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 280
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Allergy to antibiotics or gradolinium contrast
  • Current pregnancy or lactation
  • Any kidney disease or pending litigation
  • Any specific LBP diagnosis that may explain patients symptoms.

研究者

发起方
Oslo University Hospital HF, Ullevål Hospital, FORMI-Formidlingsenheten for muskel- og skjelettlidelser

相似试验

招募中
不适用
Short term antibiotic therapy in Patients with cholangitis and complete biliary drainage: A prospective multicenter trialK83.0Cholangitis
DRKS00021237Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main105
进行中(未招募)
不适用
Antibiotic treatment for patients with infectious endocarditis: continuous infusion, guided by measurements of the antibiotic concentration in the blood, versus intermittent infusions (the CONTENT study).
EUCTR2013-002807-32-DKAarhus University Hospital, Department of Cardiology40
进行中(未招募)
不适用
Antibiotic treatment in patients hospitalized with an acute exacerbation in chronic obstructive pulmonary disease. Effect of one day of antibiotic treatment compared t0 6 days of antibiotic treatment in patients who are clinically stable 24 hours after hospitalization. A prospective, randomized, double-blind trial - TaexaCOPAcute exacerbation of chronic ostructive pulmonary disease in hospitalized patients. All patients receive standard of care, and 1 day of intravenous antibiotics. In addition patients are randomized to treatment with Vibradox 200 mg QD in 5 days or matching placebo. The primary outcome variable is 6 minutes walking distance at day 14 after hospitalization.MedDRA version: 9.1Level: LLTClassification code 10056971Term: Infective exacerbation of chronic obstructive airways disease
EUCTR2007-007275-16-DKDepartment of Infetious Diseases, Odense University Hospital
进行中(未招募)
1 期
Comparison of the effect of shortened versus standard antibiotic treatment in patients infected with Gram negative bacteria with a urinary tract source of infectioGram-negative bacteremiaMedDRA version: 20.1Level: LLTClassification code 10054228Term: Gram-negative bacteremiaSystem Organ Class: 10021881 - Infections and infestations
EUCTR2019-003282-17-DKThomas Benfield380
进行中(未招募)
1 期
Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study
CTIS2024-514900-16-00Hvidovre Hospital380